Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of panic disorder.

Malcolm Lader1

  • 1Institute of Psychiatry, Denmark Hill, London, SE5 8AF, UK. m.lader@iop.kcl.ac.uk

Expert Review of Neurotherapeutics
|April 28, 2005
PubMed
Summary

Selective serotonin reuptuptake inhibitors (SSRIs) are the preferred first-line treatment for panic disorder due to their effectiveness and tolerability. Cognitive behavioral therapy is also a top choice, with research exploring combined treatment approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A review of the management of antidepressant discontinuation symptoms.

Therapeutic advances in psychopharmacology·2016
Same author

Withdrawing Benzodiazepines in Patients With Anxiety Disorders.

Current psychiatry reports·2016
Same author

Usage of benzodiazepines: A review.

International journal of psychiatry in clinical practice·2014
Same author

Benzodiazepine harm: how can it be reduced?

British journal of clinical pharmacology·2012
Same author

Dependence and withdrawal: comparison of the benzodiazepines and selective serotonin re-uptake inhibitors.

Addiction (Abingdon, England)·2012
Same author

Satisfaction with medication is correlated with outcome but not persistence in patients treated with placebo, escitalopram, or serotonin-norepinephrine reuptake inhibitors: a post hoc analysis.

The primary care companion for CNS disorders·2011

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • Panic disorder is a significant mental health condition requiring effective treatment.
  • Pharmacological and psychological interventions are key components of panic disorder management.
  • Current guidelines recommend specific medication classes and psychotherapies.

Purpose of the Study:

  • To review the efficacy and tolerability of various treatments for panic disorder.
  • To compare first-line and alternative treatment options.
  • To discuss the role of combination therapies.

Main Methods:

  • Literature review of pharmacological and psychological treatments for panic disorder.
  • Comparative analysis of treatment effectiveness and side effect profiles.
  • Discussion of treatment guidelines and emerging strategies.

Main Results:

  • Selective serotonin reuptake inhibitors (SSRIs) are effective and well-tolerated first-line pharmacotherapies.
  • Tricyclic antidepressants are equally effective but less tolerated than SSRIs.
  • Monoamine oxidase inhibitors have efficacy but significant side effects limit their use.
  • Benzodiazepines are suitable for short-term or treatment-resistant cases, with caution regarding dependence.
  • Cognitive behavioral therapy (CBT) is the primary psychologic treatment of choice.

Conclusions:

  • SSRIs and CBT are the leading first-line treatments for panic disorder.
  • Combination therapy warrants further investigation for optimal patient outcomes.
  • Treatment selection should consider individual patient factors, including tolerance and history of dependence.

Related Experiment Videos